Summary

Article Metadata

Antimalarial Study Retracted

This is a news story, published by USA Today, that relates primarily to Oransky news.

Oransky news

For more Oransky news, you can click here:

more Oransky news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

USA Today news

For more news from USA Today, you can click here:

more news from USA Today

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

novel coronavirus

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest hydroxychloroquine study news, scientific misconduct news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

antimalarial drug

USA Today

•

Health

Study retracted years after it set off an infamous COVID-19 treatment scandal

Summary

Nutrition label

81% Informative

Journal retracts study that set off flurry of interest in using antimalarial drug to treat COVID-19 .

Study was published in March 2020 as countries were shutting down and morgues filled up.

Prescriptions for hydroxychloroquine increased 80-fold between March 2019 and March 2020 .

Follow-up studies failed to confirm study's findings.

Public health officials and researchers need to acknowledge when they get things wrong.

“Otherwise, we’re just going to get into a worse and worse cycle,” Oransky says.

Oransky: “You don’t get closer to the truth by politicizing science”.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

https://my.clevelandclinic.org/health/drugs/19772-hydroxychloroquine-tablets https://retractionwatch.com/2020/04/12/elsevier-investigating-hydroxychloroquine-covid-19-paper/https://pubmed.ncbi.nlm.nih.gov/32450107/https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or https://www.sciencedirect.com/science/article/pii/S0924857920300996 https://www.science.org/content/article/unearthed-university-investigation-found-research-ethics-failings-french-medical https://www.cdc.gov/mmwr/volumes/69/wr/mm6935a4.htm https://sfpt-fr.org/vie-de-la-sfpt/communiques-sfpt/2097-retractation-de-letude-gautret-et-coll-hydroxychloroquine-azithromycine https://retractionwatch.com/https://pmc.ncbi.nlm.nih.gov/articles/PMC7267550/https://scienceintegritydigest.com/2020/03/24/thoughts-on-the-gautret-et-al-paper-about-hydroxychloroquine-and-azithromycin-treatment-of-covid-19-infections/

Source diversity

my.clevelandclinic.org retractionwatch.com pubmed.ncbi.nlm.nih.gov www.fda.gov www.sciencedirect.com www.science.org www.cdc.gov sfpt-fr.org pmc.ncbi.nlm.nih.gov scienceintegritydigest.com

Affiliate links

no affiliate links

Read full article